JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva ® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva

SHANGHAI, Jan. 10, 2025 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent and…

www.investing.com

More posts

Trump’s crypto czar, Congressional lawmakers ‘golden age’ digital assets

February 5, 2025
Bernie Sanders floats a bipartisan bill to fulfill a Trump campaign promise. Critics say it’s ‘pandering.’

February 5, 2025
US Treasury Dept gives Musk's DOGE 'read only' access to payment systems

February 5, 2025
Delaware Supreme Court eases path for some companies to leave state

February 5, 2025